Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy. [electronic resource]
Producer: 20100415Description: 40-8 p. digitalISSN:- 1099-1069
- Adult
- Aged
- Aged, 80 and over
- Chelation Therapy -- mortality
- Erythrocyte Transfusion -- mortality
- Female
- Ferritins -- metabolism
- Humans
- Iron Chelating Agents -- therapeutic use
- Iron Overload -- drug therapy
- Male
- Middle Aged
- Primary Myelofibrosis -- blood
- Prognosis
- Retrospective Studies
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.